Clinical Trial Details


Back to Clinical Trials Database

Management of low grade ductal carcinoma in situ (low-grade DCIS): a randomized, multicenter, non-inferiority trial, between standard therapy approach versus active surveillance

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 30-Jan-2017
Date Step1 close: 15-Jul-2018
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size All Groups: 1240
Treatment Radiotherapy, Drug
Study Staff Jelle Wesseling (Study Coordinator) , The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam
Melanie Beauvois (Clinical Operations Manager) , EORTC Headquarters, Brussels
Christine Bourguignon (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Livia Meirsman (Project Manager) , EORTC Headquarters, Brussels
Bart Meulemans (Data Manager) , EORTC Headquarters, Brussels
Coralie Poncet (Statistician) , EORTC Headquarters, Brussels
Sandrine Rivrain (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Type of cancer Breast
Participating groups EORTC Breast Cancer Group
Borstkanker Onderzoek Group Nederland
The Netherland Cancer Institute
Recruiting centers CHU Saint-Pierre-Site Porte de Hal (Brussels, Belgium)
Hopital Universitaire Brugmann (Brussels, Belgium)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
Universitair Ziekenhuis Antwerpen (Edegem, Belgium)
ZNA Jan Palfijn (Merksem, Belgium)
ZNA Middelheim (Antwerpen, Belgium)
Centers to be activated CHU Site Sainte-Elisabeth-UCL Namur (Namur, Belgium)
Hopital Universitaires Erasme (Brussels, Belgium)
Protocol summary
NCT number NCT02492607
Financial Support External Grant